金誉彩票欢迎您的到来!

您好,欢迎光临安诺伦(北京)生物科技商城!
全国服务热线:400-965-8633
关注我们
  • 会员中心
  • 会员中心
    询价列表
    0

    最新加入的商品

    0 件商品 合计:¥ 0
  • 会员中心
    购物车

    最新加入的商品

    件商品 合计:¥ 0

全部产品分类

优势品牌
当前位置:首页 > Mirusbio

Mirusbio


Mirus被公认为是核酸研究试剂开发的引领者,其许多杰出成就受到世界的公认。首先研发出siRNA转染试剂,作为世界上最早开发的高效、低细胞毒性转染试剂的公司之一, 向市场推出“一步法”核酸标记技术以及独特的小分子RNA,如microRNA标记技术等。


Internationally recognized gene therapy specialist, Jon Wolff, along with his colleagues James Hagstrom and Vladimir Budker founded the company in 1995, based on research they performed at the University of Wisconsin-Madison.Mirus was founded on the principle that non-viral (i.e. plasmid DNA based) methods offer distinct advantages over viral methods of gene transfer. Our initial breakthrough in 1996 came with the development of a new type of transfection reagent that combined high efficiency delivery with low cellular toxicity: TransIT®-LT1 (Low Toxicity) Reagent remains the “gold standard” for broad-based gene delivery applications.


Following this path, Mirus continued the development of a wide range of non-viral delivery technologies using proteins, polymers, and lipids in conjunction with novel chemistries that provided unique nucleic acid delivery capabilities. In 2001, our scientists applied the fundamentals of delivery to the emerging field of RNA interference and introduced the first transfection reagent specifically designed to deliver siRNA with the highest efficiencies: TransIT-TKO® Transfection Reagent.


While developing and commercializing the most relied upon transfection reagents, our commitment to the research community reached beyond delivery technologies, offering scientists tools from our bench: The Label IT® non-enzymatic nucleic acid labeling, a method of choice for studies of intracellular nucleic acid tracking. The Label IT® technology employs proprietary chemistry to covalently attach labeling molecules to DNA and RNA. This simple one-step process is faster and more robust than traditional multi-step enzymatic labeling, and can be used for intracellular tracking, chromosome analysis, and microarray labeling.With an understanding that some cell types were resistant to chemical transfection, in 2008 Mirus researchers developed and introduced: Ingenio® Electroporation Solutions, a method that can be used on any conventional device.


产品列表:


Mirusbio

MIR 6000

TransIT-X2® Dynamic Delivery System

1.5 ml

Mirusbio

MIR 6003

TransIT-X2® Dynamic Delivery System

0.3 ml

Mirusbio

MIR 6004

TransIT-X2® Dynamic Delivery System

0.75 ml

Mirusbio

MIR 6005

TransIT-X2® Dynamic Delivery System

5 x 1.5 ml

Mirusbio

MIR 6006

TransIT-X2® Dynamic Delivery System

10 x 1.5 ml

Mirusbio

MIR 2300

TransIT®-LT1 Transfection Reagent

1 ml

Mirusbio

MIR 2304

TransIT®-LT1 Transfection Reagent

0.4 ml

Mirusbio

MIR 2305

TransIT®-LT1 Transfection Reagent

5 X 1 ml

Mirusbio

MIR 2306

TransIT®-LT1 Transfection Reagent

10 X 1 ml

Mirusbio

MIR 2000

TransIT®-Express Transfection Reagent

1 ml

Mirusbio

MIR 2004

TransIT®-Express Transfection Reagent

0.4 ml

Mirusbio

MIR 2005

TransIT®-Express Transfection Reagent

5 X 1 ml

Mirusbio

MIR 2006

TransIT®-Express Transfection Reagent

10 X 1 ml

Mirusbio

MIR 5400

TransIT®-2020 Transfection Reagent

1 ml

Mirusbio

MIR 5404

TransIT®-2020 Transfection Reagent

0.4 ml

Mirusbio

MIR 5405

TransIT®-2020 Transfection Reagent

5 X 1 ml

Mirusbio

MIR 5406

TransIT®-2020 Transfection Reagent

10 X 1 ml

Mirusbio

MIR 5700

TransIT-PRO® Transfection Kit

1 ml

Mirusbio

MIR 5760

TransIT-PRO® Transfection Kit

10 ml